AKT1 and prostate carcinoma: According to the KEGG, these 21 key miRNA targets participated in proteoglycans in cancer, pathways in cancer, microRNAs in cancer, PI3K-Akt signaling pathway, chemokine signaling pathway, VEGF signaling pathway, prostate cancer, cell cycle and FoxO signaling pathway.